nodes	percent_of_prediction	percent_of_DWPC	metapath
Bacitracin—IDE—Alzheimers Disease—CASP12—amyotrophic lateral sclerosis	0.102	0.154	CbGpPWpGaD
Bacitracin—IDE—Alzheimers Disease—MAPT—amyotrophic lateral sclerosis	0.0572	0.0862	CbGpPWpGaD
Bacitracin—A2M—embryo—amyotrophic lateral sclerosis	0.043	0.128	CbGeAlD
Bacitracin—IDE—Alzheimers Disease—CASP9—amyotrophic lateral sclerosis	0.0403	0.0608	CbGpPWpGaD
Bacitracin—IDE—medulla oblongata—amyotrophic lateral sclerosis	0.0357	0.106	CbGeAlD
Bacitracin—A2M—HDL-mediated lipid transport—APOE—amyotrophic lateral sclerosis	0.0333	0.0502	CbGpPWpGaD
Bacitracin—IDE—spinal cord—amyotrophic lateral sclerosis	0.0318	0.0946	CbGeAlD
Bacitracin—A2M—medulla oblongata—amyotrophic lateral sclerosis	0.0275	0.0816	CbGeAlD
Bacitracin—A2M—Platelet degranulation—TUBA4A—amyotrophic lateral sclerosis	0.0272	0.0409	CbGpPWpGaD
Bacitracin—IDE—nervous system—amyotrophic lateral sclerosis	0.0268	0.0797	CbGeAlD
Bacitracin—IDE—Alzheimers Disease—APOE—amyotrophic lateral sclerosis	0.0267	0.0403	CbGpPWpGaD
Bacitracin—A2M—Response to elevated platelet cytosolic Ca2+—TUBA4A—amyotrophic lateral sclerosis	0.0259	0.039	CbGpPWpGaD
Bacitracin—IDE—central nervous system—amyotrophic lateral sclerosis	0.0258	0.0767	CbGeAlD
Bacitracin—IDE—cerebellum—amyotrophic lateral sclerosis	0.0253	0.075	CbGeAlD
Bacitracin—A2M—spinal cord—amyotrophic lateral sclerosis	0.0245	0.0728	CbGeAlD
Bacitracin—A2M—Platelet degranulation—PFN1—amyotrophic lateral sclerosis	0.0244	0.0369	CbGpPWpGaD
Bacitracin—A2M—Response to elevated platelet cytosolic Ca2+—PFN1—amyotrophic lateral sclerosis	0.0233	0.0351	CbGpPWpGaD
Bacitracin—A2M—nervous system—amyotrophic lateral sclerosis	0.0207	0.0613	CbGeAlD
Bacitracin—IDE—brain—amyotrophic lateral sclerosis	0.0205	0.0609	CbGeAlD
Bacitracin—A2M—central nervous system—amyotrophic lateral sclerosis	0.0199	0.0591	CbGeAlD
Bacitracin—A2M—cerebellum—amyotrophic lateral sclerosis	0.0194	0.0577	CbGeAlD
Bacitracin—A2M—Lipoprotein metabolism—APOE—amyotrophic lateral sclerosis	0.0191	0.0288	CbGpPWpGaD
Bacitracin—IDE—Alzheimers Disease—CASP3—amyotrophic lateral sclerosis	0.017	0.0256	CbGpPWpGaD
Bacitracin—A2M—brain—amyotrophic lateral sclerosis	0.0158	0.0469	CbGeAlD
Bacitracin—A2M—Lipid and lipoprotein metabolism—APOE—amyotrophic lateral sclerosis	0.0127	0.0192	CbGpPWpGaD
Bacitracin—A2M—Platelet activation, signaling and aggregation—TUBA4A—amyotrophic lateral sclerosis	0.012	0.0182	CbGpPWpGaD
Bacitracin—A2M—Platelet degranulation—SOD1—amyotrophic lateral sclerosis	0.0118	0.0178	CbGpPWpGaD
Bacitracin—A2M—Response to elevated platelet cytosolic Ca2+—SOD1—amyotrophic lateral sclerosis	0.0113	0.017	CbGpPWpGaD
Bacitracin—IDE—Alzheimers Disease—TP53—amyotrophic lateral sclerosis	0.0109	0.0164	CbGpPWpGaD
Bacitracin—A2M—Platelet activation, signaling and aggregation—PFN1—amyotrophic lateral sclerosis	0.0108	0.0163	CbGpPWpGaD
Bacitracin—A2M—Metabolism of lipids and lipoproteins—VAPB—amyotrophic lateral sclerosis	0.0108	0.0162	CbGpPWpGaD
Bacitracin—A2M—Metabolism of lipids and lipoproteins—VAPA—amyotrophic lateral sclerosis	0.00984	0.0148	CbGpPWpGaD
Bacitracin—A2M—Metabolism of lipids and lipoproteins—SACM1L—amyotrophic lateral sclerosis	0.00915	0.0138	CbGpPWpGaD
Bacitracin—A2M—Hemostasis—KIFAP3—amyotrophic lateral sclerosis	0.00896	0.0135	CbGpPWpGaD
Bacitracin—A2M—Metabolism of lipids and lipoproteins—FIG4—amyotrophic lateral sclerosis	0.0086	0.013	CbGpPWpGaD
Bacitracin—A2M—Platelet degranulation—IGF1—amyotrophic lateral sclerosis	0.00721	0.0109	CbGpPWpGaD
Bacitracin—A2M—Response to elevated platelet cytosolic Ca2+—IGF1—amyotrophic lateral sclerosis	0.00687	0.0104	CbGpPWpGaD
Bacitracin—A2M—Hemostasis—TUBA4A—amyotrophic lateral sclerosis	0.00621	0.00936	CbGpPWpGaD
Bacitracin—A2M—Metabolism of lipids and lipoproteins—PLB1—amyotrophic lateral sclerosis	0.00589	0.00889	CbGpPWpGaD
Bacitracin—A2M—Hemostasis—RAB5A—amyotrophic lateral sclerosis	0.00577	0.0087	CbGpPWpGaD
Bacitracin—A2M—Hemostasis—PFN1—amyotrophic lateral sclerosis	0.00559	0.00843	CbGpPWpGaD
Bacitracin—A2M—Platelet activation, signaling and aggregation—SOD1—amyotrophic lateral sclerosis	0.00524	0.0079	CbGpPWpGaD
Bacitracin—A2M—Degradation of the extracellular matrix—CASP3—amyotrophic lateral sclerosis	0.00509	0.00768	CbGpPWpGaD
Bacitracin—A2M—Degradation of the extracellular matrix—MMP9—amyotrophic lateral sclerosis	0.00481	0.00726	CbGpPWpGaD
Bacitracin—A2M—Metabolism—VAPB—amyotrophic lateral sclerosis	0.00479	0.00722	CbGpPWpGaD
Bacitracin—A2M—Metabolism—TPK1—amyotrophic lateral sclerosis	0.00479	0.00722	CbGpPWpGaD
Bacitracin—A2M—Platelet degranulation—VEGFA—amyotrophic lateral sclerosis	0.00471	0.0071	CbGpPWpGaD
Bacitracin—A2M—Platelet activation, signaling and aggregation—PLA2G4A—amyotrophic lateral sclerosis	0.0047	0.00709	CbGpPWpGaD
Bacitracin—A2M—Response to elevated platelet cytosolic Ca2+—VEGFA—amyotrophic lateral sclerosis	0.00448	0.00676	CbGpPWpGaD
Bacitracin—A2M—Metabolism of lipids and lipoproteins—CHAT—amyotrophic lateral sclerosis	0.00447	0.00674	CbGpPWpGaD
Bacitracin—A2M—Metabolism—VAPA—amyotrophic lateral sclerosis	0.00438	0.00661	CbGpPWpGaD
Bacitracin—A2M—Metabolism—SACM1L—amyotrophic lateral sclerosis	0.00407	0.00614	CbGpPWpGaD
Bacitracin—A2M—Metabolism—FIG4—amyotrophic lateral sclerosis	0.00383	0.00578	CbGpPWpGaD
Bacitracin—A2M—Metabolism—DAO—amyotrophic lateral sclerosis	0.00346	0.00522	CbGpPWpGaD
Bacitracin—A2M—Platelet activation, signaling and aggregation—IGF1—amyotrophic lateral sclerosis	0.0032	0.00482	CbGpPWpGaD
Bacitracin—A2M—Hemostasis—SOD1—amyotrophic lateral sclerosis	0.0027	0.00407	CbGpPWpGaD
Bacitracin—A2M—Metabolism—PLB1—amyotrophic lateral sclerosis	0.00263	0.00396	CbGpPWpGaD
Bacitracin—A2M—Hemostasis—PLA2G4A—amyotrophic lateral sclerosis	0.00242	0.00365	CbGpPWpGaD
Bacitracin—A2M—Metabolism—GSR—amyotrophic lateral sclerosis	0.00242	0.00365	CbGpPWpGaD
Bacitracin—A2M—Metabolism of lipids and lipoproteins—PLA2G4A—amyotrophic lateral sclerosis	0.00221	0.00333	CbGpPWpGaD
Bacitracin—A2M—Signaling Pathways—PLB1—amyotrophic lateral sclerosis	0.0022	0.00331	CbGpPWpGaD
Bacitracin—A2M—Extracellular matrix organization—CASP3—amyotrophic lateral sclerosis	0.00213	0.00322	CbGpPWpGaD
Bacitracin—A2M—Platelet activation, signaling and aggregation—VEGFA—amyotrophic lateral sclerosis	0.00209	0.00315	CbGpPWpGaD
Bacitracin—A2M—Signaling Pathways—RTN4—amyotrophic lateral sclerosis	0.00206	0.00311	CbGpPWpGaD
Bacitracin—A2M—Extracellular matrix organization—MMP9—amyotrophic lateral sclerosis	0.00202	0.00304	CbGpPWpGaD
Bacitracin—A2M—Metabolism—CHAT—amyotrophic lateral sclerosis	0.00199	0.003	CbGpPWpGaD
Bacitracin—A2M—Signaling Pathways—VCP—amyotrophic lateral sclerosis	0.00196	0.00295	CbGpPWpGaD
Bacitracin—A2M—Signaling Pathways—PFN1—amyotrophic lateral sclerosis	0.00189	0.00286	CbGpPWpGaD
Bacitracin—A2M—Metabolism of lipids and lipoproteins—APOE—amyotrophic lateral sclerosis	0.00182	0.00274	CbGpPWpGaD
Bacitracin—A2M—Signaling Pathways—GFAP—amyotrophic lateral sclerosis	0.00168	0.00254	CbGpPWpGaD
Bacitracin—A2M—Signaling Pathways—C5AR1—amyotrophic lateral sclerosis	0.00166	0.00251	CbGpPWpGaD
Bacitracin—A2M—Hemostasis—IGF1—amyotrophic lateral sclerosis	0.00165	0.00248	CbGpPWpGaD
Bacitracin—A2M—Metabolism of lipids and lipoproteins—PTGS2—amyotrophic lateral sclerosis	0.00124	0.00188	CbGpPWpGaD
Bacitracin—A2M—Signaling Pathways—SQSTM1—amyotrophic lateral sclerosis	0.00114	0.00172	CbGpPWpGaD
Bacitracin—A2M—Hemostasis—VEGFA—amyotrophic lateral sclerosis	0.00108	0.00162	CbGpPWpGaD
Bacitracin—A2M—Signaling Pathways—ATF1—amyotrophic lateral sclerosis	0.00107	0.00162	CbGpPWpGaD
Bacitracin—A2M—Metabolism—GSTP1—amyotrophic lateral sclerosis	0.00107	0.00161	CbGpPWpGaD
Bacitracin—A2M—Signaling Pathways—CASP9—amyotrophic lateral sclerosis	0.00102	0.00154	CbGpPWpGaD
Bacitracin—A2M—Metabolism—PLA2G4A—amyotrophic lateral sclerosis	0.000983	0.00148	CbGpPWpGaD
Bacitracin—A2M—Signaling Pathways—ERBB4—amyotrophic lateral sclerosis	0.000874	0.00132	CbGpPWpGaD
Bacitracin—A2M—Signaling Pathways—PLA2G4A—amyotrophic lateral sclerosis	0.000822	0.00124	CbGpPWpGaD
Bacitracin—A2M—Hemostasis—TP53—amyotrophic lateral sclerosis	0.000813	0.00123	CbGpPWpGaD
Bacitracin—A2M—Metabolism—APOE—amyotrophic lateral sclerosis	0.000808	0.00122	CbGpPWpGaD
Bacitracin—A2M—Signaling Pathways—C3—amyotrophic lateral sclerosis	0.000726	0.00109	CbGpPWpGaD
Bacitracin—A2M—Signaling Pathways—APOE—amyotrophic lateral sclerosis	0.000676	0.00102	CbGpPWpGaD
Bacitracin—A2M—Signaling Pathways—IGF1—amyotrophic lateral sclerosis	0.000559	0.000842	CbGpPWpGaD
Bacitracin—A2M—Metabolism—PTGS2—amyotrophic lateral sclerosis	0.000554	0.000835	CbGpPWpGaD
Bacitracin—A2M—Signaling Pathways—CASP3—amyotrophic lateral sclerosis	0.00043	0.000648	CbGpPWpGaD
Bacitracin—A2M—Signaling Pathways—MMP9—amyotrophic lateral sclerosis	0.000406	0.000613	CbGpPWpGaD
Bacitracin—A2M—Signaling Pathways—VEGFA—amyotrophic lateral sclerosis	0.000365	0.00055	CbGpPWpGaD
Bacitracin—A2M—Signaling Pathways—TP53—amyotrophic lateral sclerosis	0.000276	0.000416	CbGpPWpGaD
